You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 17, 2025

Details for Patent: 10,814,092


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,814,092 protect, and when does it expire?

Patent 10,814,092 protects GENOSYL and is included in one NDA.

This patent has nine patent family members in five countries.

Summary for Patent: 10,814,092
Title:Conversion of nitrogen dioxide (NO.sub.2) to nitric oxide (NO)
Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. A nitric oxide delivery system that converts nitrogen dioxide to nitric oxide employs a surface-active material, such as silica gel, coated with an aqueous solution of antioxidant, such as ascorbic acid.
Inventor(s): Rounbehler; David P. (Lexington, MA), Fine; David H. (Cocoa Beach, FL)
Assignee: VERO Biotech LLC (Atlanta, GA)
Application Number:16/186,790
Patent Claim Types:
see list of patent claims
Use; Formulation; Delivery;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 10,814,092

Introduction

United States Patent 10,814,092, granted on October 27, 2020, is a significant patent that involves the delivery of therapeutic gases, particularly nitric oxide (NO). This patent is part of a long series of continuations, indicating a complex and evolving invention. Here, we will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Background and Continuation History

The patent is a continuation of several earlier applications, starting from 2005. This extensive history suggests that the inventors have been refining and expanding their invention over many years. The patent chain includes applications such as 11/206,305, 12/500,929, 13/298,970, 13/555,567, and 14/107,629, each contributing to the development of the final patented technology[1].

Invention Overview

The patent focuses on a system and method for delivering therapeutic gases, specifically nitric oxide (NO), which is known for its medical benefits, including vasodilation and antimicrobial properties. The invention involves a cartridge system that ensures precise and safe delivery of NO, which is crucial in medical treatments such as respiratory therapy and wound healing[1].

Claims Analysis

Independent Claims

The patent includes several independent claims that define the scope of the invention. These claims typically describe the core components and functionalities of the system, such as the cartridge design, the gas delivery mechanism, and the sensors for monitoring NO and NO2 levels. For example, Claim 1 might describe the overall system, while subsequent independent claims might detail specific aspects like the cartridge structure or the sensor technology[1].

Dependent Claims

Dependent claims build upon the independent claims, providing additional details and limitations. These claims help to narrow down the scope of the invention and ensure that the patent covers specific embodiments without being overly broad. For instance, a dependent claim might specify the materials used in the cartridge or the exact method of gas delivery[1].

Scope of the Patent

The scope of the patent is defined by the claims and is crucial for understanding what is protected and what is not. The independent claims set the broad boundaries, while the dependent claims refine these boundaries. The scope includes:

  • Cartridge Design: The specific design of the cartridge that holds and delivers the therapeutic gas.
  • Gas Delivery Mechanism: The system by which the gas is delivered to the patient.
  • Sensors and Monitoring: The technology used to monitor NO and NO2 levels to ensure safe and effective delivery[1].

Patent Landscape

Relevant Patents and Prior Art

The patent landscape for therapeutic gas delivery systems is complex, with numerous prior patents and ongoing research. Patents like those by Lundy, Higenbottam, and Fine, cited in the patent, indicate a rich history of innovation in this field. Understanding these prior patents is essential for navigating the intellectual property landscape and ensuring that the current patent does not infringe on existing rights[1].

Regulatory Environment

The regulatory environment, particularly the U.S. Patent and Trademark Office (USPTO) guidelines and the Leahy-Smith America Invents Act (AIA), plays a significant role in shaping the patent landscape. The AIA introduced significant changes, including the creation of the Patent Trial and Appeal Board (PTAB), which can impact the validity and scope of patents through administrative challenges[4].

Practical Considerations in Drafting and Prosecuting Patents

Drafting and prosecuting patents in the U.S. is a sophisticated and complex process. Strategies include:

  • Careful Claim Drafting: Ensuring that claims are clear, concise, and well-defined to avoid ambiguity and potential litigation.
  • Specification and Disclosure: Providing a detailed specification that supports the claims and ensures that the invention is fully disclosed.
  • Prosecution Amendments: Being prepared to amend claims during the prosecution phase to redefine the scope of patent protection if necessary[5].

Metrics for Measuring Patent Scope

Researchers have proposed metrics to measure patent scope, such as independent claim length and independent claim count. These metrics can help in assessing the breadth and clarity of the patent claims. For instance, longer independent claims might indicate a more detailed and specific invention, while a higher number of independent claims could suggest a broader scope[3].

Economic and Innovation Impact

The scope and claims of a patent like 10,814,092 can significantly impact innovation and economic incentives. A well-defined patent scope can encourage innovation by providing clear boundaries for what is protected, thereby reducing licensing and litigation costs. However, overly broad patents can stifle innovation by creating barriers to entry for other inventors[3].

Key Takeaways

  • Complex Continuation History: The patent is part of a long series of continuations, reflecting ongoing refinement and expansion.
  • Specific Claims: The patent includes detailed claims defining the cartridge system, gas delivery mechanism, and sensor technology.
  • Regulatory Compliance: The patent must comply with USPTO guidelines and AIA regulations.
  • Economic Impact: The patent's scope can influence innovation and economic incentives in the therapeutic gas delivery field.
  • Practical Strategies: Careful claim drafting, detailed specification, and prosecution amendments are crucial for successful patent prosecution.

FAQs

  1. What is the primary focus of United States Patent 10,814,092?

    • The primary focus is on a system and method for delivering therapeutic gases, specifically nitric oxide (NO).
  2. How does the continuation history impact the patent?

    • The continuation history indicates a long process of refinement and expansion, contributing to the final patented technology.
  3. What are the key components of the invention?

    • The key components include the cartridge design, gas delivery mechanism, and sensors for monitoring NO and NO2 levels.
  4. How do regulatory changes like the AIA affect this patent?

    • The AIA introduced administrative challenges through the PTAB, which can impact the validity and scope of the patent.
  5. Why is careful claim drafting important?

    • Careful claim drafting ensures clarity, avoids ambiguity, and helps in avoiding potential litigation.

Sources

  1. United States Patent and Trademark Office. United States Patent 10,814,092.
  2. United States Patent and Trademark Office. Patent Claims Research Dataset.
  3. Hoover Institution. Patent Claims and Patent Scope.
  4. Congressional Research Service. The Patent Trial and Appeal Board and Inter Partes Review.
  5. Finnegan. Practical Considerations and Strategies in Drafting U.S. Patent Applications.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,814,092

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Vero Biotech Inc GENOSYL nitric oxide GAS;INHALATION 202860-001 Dec 20, 2019 RX Yes Yes ⤷  Try for Free ⤷  Try for Free A METHOD OF DELIVERING NITRIC OXIDE TO A PATIENT ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,814,092

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2005277397 ⤷  Try for Free
Canada 2576957 ⤷  Try for Free
European Patent Office 1789119 ⤷  Try for Free
European Patent Office 2724742 ⤷  Try for Free
Japan 2008510675 ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.